Provided by Tiger Trade Technology Pte. Ltd.

TELIX PHARMACEUTICALS LTD

15.160
-0.450-2.88%
Volume:2.58M
Turnover:39.09M
Market Cap:5.14B
PE:110.35
High:15.510
Open:15.410
Low:14.880
Close:15.610
52wk High:18.220
52wk Low:8.260
Shares:338.72M
Float Shares:275.41M
Volume Ratio:1.36
T/O Rate:0.94%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.137
EPS(LYR):-0.030
ROE:7.36%
ROA:2.71%
PB:7.31
PE(LYR):-498.85

Loading ...

Telix Stock And 2 Australian Growth Shares With High Insider Ownership

Simply Wall St.
·
Jul 28

3 Australian Growth Stocks Where Insider Ownership Could Matter Most

Simply Wall St.
·
Jul 26

Telix Stock And Other Fast Growing Insider Owned Shares Worth A Closer Look

Simply Wall St.
·
Jul 24

Telix Says Thyroid Cancer Therapy Candidate Shows Encouraging Disease Control, Acceptable Safety Profile in Real-World Data Review

MT Newswires Live
·
Jul 24

3 Australian Growth Stocks With High Insider Ownership Worth A Closer Look

Simply Wall St.
·
Jul 23

3 Australian Growth Stocks Where Insider Ownership Signals Stronger Conviction

Simply Wall St.
·
Jul 22

U.S. Stocks on the Move-duke Robotics, Tesla, Hasbro

Reuters
·
Jul 22

U.S. Stocks on the Move-utz Brands, Tutor Perini, Tripadvisor

Reuters
·
Jul 21

Telix Pharmaceuticals Carries Meaningful Upside on Potential Product Approvals, Jefferies Says

MT Newswires Live
·
Jul 21

3 Australian Growth Stocks Trading Below Fair Value With Strong Insider Backing

Simply Wall St.
·
Jul 21

Australia's Telix Pharmaceuticals Gains on Upbeat Quarterly Revenue

Reuters
·
Jul 21

Telix Q2 Revenue Us$247m, Strong Momentum and Pipeline Progress

THOMSON REUTERS
·
Jul 21

Telix Appoints Three New Non-executive Directors to Expanded Board

Reuters
·
Jul 21

Telix Expects Fy2026 Revenue and Other Income Above US$1 Billion, Tracks Upper End of Guidance Range

Reuters
·
Jul 21

Telix Pharmaceuticals Ltd - Telix Expects FY 2026 Revenue and Other Income to be in Excess of US$1 Bln

THOMSON REUTERS
·
Jul 21

Telix Doses First Patient in Phase 3 Luteon Trial of Tlx250-tx for Renal Cancer

THOMSON REUTERS
·
Jul 21

3 Australian Growth Stocks With High Insider Ownership Worth A Closer Look

Simply Wall St.
·
Jul 20

3 Australian Growth Stocks Where Insider Ownership Signals Stronger Conviction

Simply Wall St.
·
Jul 17

Telix Pharmaceuticals Completes Phase Three Enrollment for Prostate Cancer Imaging Study in Japan

MT Newswires Live
·
Jul 17

Telix Pharmaceuticals Opens Radiopharmaceutical Research, Manufacturing, Treatment Facility in Melbourne

MT Newswires Live
·
Jul 16